Australian Gonococcal Surveillance Programme: Reporting period 1 January to 31 March 2019
DOI:
https://doi.org/10.33321/%20cdi.2020.44.3Keywords:
Gonorrhoea, gonococcal, antimicrobial resistance, disease surveillanceDownloads
References
European Centre for Disease Prevention and Control. Rapid Risk Assessment: Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia – 7 May 2018. [Internet.] Stockholm: ECDC, 2018. [Accessed: 16 May 2019.] Available from: https://ecdc.europa.eu/sites/portal/files/documents/RRA-Gonorrhoea%2C%20Antimicrobial%20resistance-United%20Kingdom%2C%20Australia.pdf
Lahra MM, Enriquez RP. Australian Gonococcal Surveillance Programme. Annual Report 2016. Commun Dis Intell (2018). 2018;42. pii: S2209-5081(18)00013-1.
Unemo M. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364.
Australasian Sexual Health Alliance. Australian STI management guidelines for use in primary care: Gonorrhoea: Follow up. [Internet.] Australasian Sexual Health Alliance, 2018. [Accessed on: 16 May 2019.] Available from: http://www.sti.guidelines.org.au/sexually-transmissible-infections/gonorrhoea#follow-up
Published
How to Cite
License
Copyright (c) 2023 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
